There was clinical evidence for elevated plasma ET-1 levels in patients with T2DM, leading to endothelial dysfunction, which are actively involved in the pathophysiology of the onset and progression of coronary artery disease (Zhang et al., 2020; Yang et al., 2024). Here, EDN1 is linked to endothelial dysfunction.